Design We evaluated 2 educational interventions (DrugFactsBoxes and the SMART program) using a 2 × 2 factorial research design and adhering to Consolidated Standards of Reporting Trials… Read More »Enhancing Patient Understanding of Medication Risks and Benefits
1 Introduction Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS) affecting ≈2.5 million people around the world. The… Read More »Therapeutic Potentials of Poly (ADP‐Ribose) Polymerase 1 (PARP1) Inhibition in Multiple Sclerosis and Animal Models: Concept Revisiting
1 INTRODUCTION Advancements in biology and cancer therapy for pediatric malignancies have resulted in dramatic improvement in survival of children with cancer. Current 5-year survival… Read More »Physical activity and fitness in childhood cancer survivors: A scoping review